GR74714B - - Google Patents

Info

Publication number
GR74714B
GR74714B GR67535A GR820167535A GR74714B GR 74714 B GR74714 B GR 74714B GR 67535 A GR67535 A GR 67535A GR 820167535 A GR820167535 A GR 820167535A GR 74714 B GR74714 B GR 74714B
Authority
GR
Greece
Application number
GR67535A
Inventor
William Henry Walker Lunn
John Kevin Shadle
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of GR74714B publication Critical patent/GR74714B/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR67535A 1981-03-11 1982-03-09 GR74714B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/242,792 US4336253A (en) 1981-03-11 1981-03-11 Cephalosporin antibiotics

Publications (1)

Publication Number Publication Date
GR74714B true GR74714B (el) 1984-07-06

Family

ID=22916202

Family Applications (1)

Application Number Title Priority Date Filing Date
GR67535A GR74714B (el) 1981-03-11 1982-03-09

Country Status (21)

Country Link
US (1) US4336253A (el)
EP (1) EP0060144A3 (el)
JP (1) JPS57165393A (el)
KR (1) KR830009119A (el)
AU (1) AU8091182A (el)
BG (1) BG36936A3 (el)
CA (1) CA1177066A (el)
CS (1) CS238620B2 (el)
DD (1) DD201599A5 (el)
DK (1) DK100982A (el)
ES (1) ES510307A0 (el)
FI (1) FI820806L (el)
GB (1) GB2094309B (el)
GR (1) GR74714B (el)
IL (1) IL65185A0 (el)
NZ (1) NZ199959A (el)
PH (1) PH17022A (el)
PL (1) PL130568B1 (el)
PT (1) PT74558B (el)
RO (1) RO82962B (el)
ZA (1) ZA821525B (el)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443444A (en) * 1980-08-11 1984-04-17 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
DE3118732A1 (de) * 1981-05-12 1982-12-02 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
US4450270A (en) * 1981-10-02 1984-05-22 Eli Lilly And Company Dioximino cephalosporin antibiotics
US4616081A (en) * 1982-07-07 1986-10-07 Asahi Kasei Kogyo Kabushiki Kaisha Cephalosporin compounds
DE3316797A1 (de) * 1983-05-07 1984-11-08 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von cephemverbindungen
DE3316798A1 (de) * 1983-05-07 1984-11-08 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von cephemverbindungen
EP0612750B1 (de) * 1984-11-23 1999-03-03 BIOCHEMIE Gesellschaft m.b.H. Cephalosporinderivative
US4703118A (en) * 1985-04-08 1987-10-27 Eli Lilly And Company Synthesis of 3-iodomethyl cephalosporins
US4714760A (en) * 1985-08-20 1987-12-22 Bristol-Myers Company Cephalosporin intermediates
US4749522A (en) * 1985-10-31 1988-06-07 Angio-Medical Corporation Supercritical fluid extraction of animal derived materials
US4868294A (en) * 1986-07-11 1989-09-19 Bristol-Myers Company Process for preparing cephalosporin intermediates
PL1618114T3 (pl) 2003-04-16 2010-12-31 Sandoz Ag Sposoby otrzymywania cefepimy
US7847093B2 (en) * 2003-04-16 2010-12-07 Sandoz Ag Processes for the preparations of cefepime
US20070111980A1 (en) * 2004-07-16 2007-05-17 Bandi Parthasaradhi Reddy Process for preparing pure cephalosporine intermediates
EA028342B1 (ru) 2011-09-09 2017-11-30 Мерк Шарп И Доум Корп. Способы лечения пневмонии
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US20140274996A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Tazobactam and ceftolozane antibiotic compositions
US20140274994A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Stabilizing ceftolozane
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
EP3043797B1 (en) 2013-09-09 2020-04-08 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3792047A (en) * 1971-12-07 1974-02-12 Glaxo Lab Ltd N-(7,2'-thienylacetamidoceph-3-em-3-ylmethyl)-3"or 4"-n-hydroxyloweralkylcarbamoyl-pyridinium-4-carboxylates
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
JPS52125188A (en) 1976-04-14 1977-10-20 Takeda Chem Ind Ltd Cephalosporin derivatives and their preparation
DE2715385A1 (de) * 1976-04-14 1977-11-10 Takeda Chemical Industries Ltd Cephalosporinderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
JPS6011713B2 (ja) * 1976-09-08 1985-03-27 武田薬品工業株式会社 セフアロスポリン誘導体およびその製造法
AR229883A1 (es) * 1978-05-26 1983-12-30 Glaxo Group Ltd Procedimiento para la preparacion de antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)-acetamido)-3-(1-piridinometil)-cef-3-em-4-carboxilato
ZA792581B (en) 1978-05-26 1981-01-28 Glaxo Group Ltd Cephalosporin antibiotics
GB2027692B (en) 1978-05-26 1983-02-09 Glaxo Group Ltd Cephalosporin antibiotics
DK78580A (da) 1979-02-23 1980-08-24 Glaxo Group Ltd Fremgangsmaade til fremstilling af cephalosporinantibiotika
US4237128A (en) * 1979-04-12 1980-12-02 E. R. Squibb & Sons, Inc. 7-[2-(2-Amino-4-thiazolyl)-2-[(1-carboxy-1,1-dialkyl)alkoxyimino]acetamido]cephem sulfoxides

Also Published As

Publication number Publication date
PL130568B1 (en) 1984-08-31
RO82962A (ro) 1984-01-14
EP0060144A2 (en) 1982-09-15
PL235396A1 (el) 1982-09-27
EP0060144A3 (en) 1983-09-14
FI820806L (fi) 1982-09-12
DD201599A5 (de) 1983-07-27
PT74558B (en) 1984-11-27
GB2094309A (en) 1982-09-15
GB2094309B (en) 1985-03-27
ES8303426A1 (es) 1983-02-01
IL65185A0 (en) 1982-05-31
DK100982A (da) 1982-09-12
CA1177066A (en) 1984-10-30
NZ199959A (en) 1985-08-16
CS238620B2 (en) 1985-12-16
US4336253A (en) 1982-06-22
AU8091182A (en) 1982-09-16
RO82962B (ro) 1984-01-30
ES510307A0 (es) 1983-02-01
BG36936A3 (en) 1985-02-15
PH17022A (en) 1984-05-11
KR830009119A (ko) 1983-12-17
ZA821525B (en) 1983-03-30
JPS57165393A (en) 1982-10-12
PT74558A (en) 1982-04-01

Similar Documents

Publication Publication Date Title
FR2499026B1 (el)
FR2499405B1 (el)
GR75506B (el)
FR2498494B1 (el)
FR2499947B3 (el)
FR2498976B1 (el)
FR2500266B1 (el)
FR2497467B1 (el)
FR2499326B1 (el)
FR2500652B3 (el)
FR2499045B1 (el)
FR2499972B1 (el)
FR2499785B1 (el)
CH655443B (el)
FR2498689B1 (el)
FR2499864B1 (el)
GR77251B (el)
FR2497699B1 (el)
FR2500278B1 (el)
FR2500621B1 (el)
FR2497507B3 (el)
FR2498387B1 (el)
FR2499924B1 (el)
FR2500662B1 (el)
FR2500702B1 (el)